I am a long term holder of NEU but must admit to being somewhat disillusioned and I hope that I have got it all wrong. If I am wrong then please set me straight.
If we successfully complete the current Rett trial then it is possible (not certain) that some “big pharma” company will make a deal…. That deal will likely be something along the lines of some cash up front and a set of arrangements re Phase 3 and manufacturing …. with the big licks of money down the track by a few years, all going well.
At a share price currently of about 6 cents the market cap is approx. $100 million.
If the cash up front payment in any deal is (say) $50 million then aren’t we at a share price of 9 cents … or maybe 10?
Remember that out current band of executives are going to want to continue for a few years more at their VERY high salaries (Treagus approx $500k per annum) so they will start spending our funds on further tests and trials, with the “ready to market” status still several years away.
Please set me straight if I am wrong.
the best Disallowed bio in 2017 will be NEU, page-12
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.18 |
Change
-0.430(3.16%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $13.64 | $13.67 | $13.18 | $8.868M | 666.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 5233 | $13.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.24 | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |